As of 2026-11-08, the EV/EBITDA ratio of NantHealth Inc (NH) is -8.90. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NH's latest enterprise value is 336.09 mil USD. NH's TTM EBITDA according to its financial statements is -37.78 mil USD. Dividing these 2 quantities gives us the above NH EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 5.3x - 10.8x | 6.6x |
| Forward P/E multiples | 6.7x - 14.2x | 9.0x |
| Fair Price | (75.33) - (95.34) | (80.28) |
| Upside | -5680.1% - -7162.2% | -6047.0% |
| Date | EV/EBITDA |